Zhejiang Shouxiangu Pharm Co - Asset Resilience Ratio

Latest as of March 2026: 12.69%

Zhejiang Shouxiangu Pharm Co (603896) has an Asset Resilience Ratio of 12.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥408.33 Million

≈ $59.75 Million USD Cash + Short-term Investments

Total Assets

CN¥3.22 Billion

≈ $470.95 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Zhejiang Shouxiangu Pharm Co's Asset Resilience Ratio has changed over time. Check Zhejiang Shouxiangu Pharm Co PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Shouxiangu Pharm Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Shouxiangu Pharm Co (603896) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥408.33 Million	12.69%
Total Liquid Assets	CN¥408.33 Million	12.69%

Asset Resilience Insights

Moderate Liquidity: Zhejiang Shouxiangu Pharm Co has 12.69% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Shouxiangu Pharm Co Industry Peers by Asset Resilience Ratio

Compare Zhejiang Shouxiangu Pharm Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Prostemics Co. Ltd KQ:203690	Biotechnology	0.31%
ORUM KQ:475830	Biotechnology	82.74%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
TG Therapeutics Inc NASDAQ:TGTX	Biotechnology	4.72%
Green Cross Holdings Preference Shares KO:005257	Biotechnology	0.50%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	33.70%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Cybin Inc NEO:CYBN	Biotechnology	0.21%

Annual Asset Resilience Ratio for Zhejiang Shouxiangu Pharm Co (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Shouxiangu Pharm Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.85%	CN¥356.16 Million ≈ $52.12 Million	CN¥3.28 Billion ≈ $480.19 Million	-0.15pp
2024-12-31	11.01%	CN¥344.69 Million ≈ $50.44 Million	CN¥3.13 Billion ≈ $458.19 Million	+9.96pp
2022-12-31	1.05%	CN¥30.00 Million ≈ $4.39 Million	CN¥2.86 Billion ≈ $417.95 Million	-5.57pp
2021-12-31	6.62%	CN¥130.00 Million ≈ $19.02 Million	CN¥1.96 Billion ≈ $287.17 Million	+3.68pp
2020-12-31	2.94%	CN¥50.00 Million ≈ $7.32 Million	CN¥1.70 Billion ≈ $248.70 Million	-11.86pp
2019-12-31	14.80%	CN¥198.50 Million ≈ $29.05 Million	CN¥1.34 Billion ≈ $196.20 Million	+12.18pp
2018-12-31	2.62%	CN¥31.22 Million ≈ $4.57 Million	CN¥1.19 Billion ≈ $174.36 Million	-20.91pp
2017-12-31	23.53%	CN¥218.00 Million ≈ $31.90 Million	CN¥926.34 Million ≈ $135.55 Million	+21.79pp
2016-12-31	1.74%	CN¥10.67 Million ≈ $1.56 Million	CN¥612.10 Million ≈ $89.57 Million	-0.82pp
2015-12-31	2.56%	CN¥15.50 Million ≈ $2.27 Million	CN¥605.91 Million ≈ $88.66 Million	--

pp = percentage points

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology

Market Cap

$423.25 Million

CN¥2.89 Billion CNY

Market Cap Rank

#13102 Global

#3866 in China

Share Price

CN¥14.59

Change (1 day)

-0.41%

52-Week Range

CN¥12.95 - CN¥22.65

All Time High

CN¥56.07